Charles Schwab’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $436M | Buy |
5,121,302
+172,372
| +3% | +$15.4M | 0.07% | 243 |
|
|
2025
Q4 | $391M | Buy |
4,948,930
+96,098
| +2% | +$7.53M | 0.06% | 257 |
|
|
2025
Q3 | $388M | Buy |
4,852,832
+21,348
| +0.4% | +$1.82M | 0.06% | 258 |
|
|
2025
Q2 | $439M | Buy |
4,831,484
+72,349
| +2% | +$6.6M | 0.08% | 223 |
|
|
2025
Q1 | $446M | Buy |
4,759,135
+27,124
| +0.6% | +$2.43M | 0.08% | 199 |
|
|
2024
Q4 | $430M | Buy |
4,732,011
+136,766
| +3% | +$13.1M | 0.08% | 209 |
|
|
2024
Q3 | $477M | Buy |
4,595,245
+11,750
| +0.3% | +$1.2M | 0.09% | 186 |
|
|
2024
Q2 | $445M | Buy |
4,583,495
+88,930
| +2% | +$8.2M | 0.08% | 197 |
|
|
2024
Q1 | $405M | Buy |
4,494,565
+68,135
| +2% | +$5.77M | 0.09% | 190 |
|
|
2023
Q4 | $353M | Buy |
4,426,430
+77,679
| +2% | +$5.84M | 0.09% | 193 |
|
|
2023
Q3 | $309M | Buy |
4,348,751
+34,546
| +0.8% | +$2.58M | 0.09% | 204 |
|
|
2023
Q2 | $332M | Sell |
4,314,205
-42,561
| -1% | -$3.29M | 0.09% | 190 |
|
|
2023
Q1 | $327M | Sell |
4,356,766
-1,105,551
| -20% | -$82.2M | 0.1% | 182 |
|
|
2022
Q4 | $426M | Buy |
5,462,317
+88,658
| +2% | +$6.65M | 0.14% | 135 |
|
|
2022
Q3 | $378M | Buy |
5,373,659
+82,963
| +2% | +$6.51M | 0.14% | 137 |
|
|
2022
Q2 | $424M | Sell |
5,290,696
-1,134,260
| -18% | -$88.7M | 0.15% | 124 |
|
|
2022
Q1 | $487M | Sell |
6,424,956
-937,861
| -13% | -$74.3M | 0.15% | 126 |
|
|
2021
Q4 | $628M | Buy |
7,362,817
+209,017
| +3% | +$16.3M | 0.19% | 100 |
|
|
2021
Q3 | $541M | Buy |
7,153,800
+146,648
| +2% | +$11.6M | 0.18% | 107 |
|
|
2021
Q2 | $570M | Buy |
7,007,152
+139,993
| +2% | +$11.4M | 0.19% | 99 |
|
|
2021
Q1 | $541M | Buy |
6,867,159
+30,488
| +0.4% | +$2.39M | 0.2% | 95 |
|
|
2020
Q4 | $585M | Sell |
6,836,671
-91,675
| -1% | -$7.58M | 0.23% | 83 |
|
|
2020
Q3 | $535M | Sell |
6,928,346
-253,680
| -4% | -$19.3M | 0.25% | 82 |
|
|
2020
Q2 | $526M | Sell |
7,182,026
-36,542
| -0.5% | -$2.6M | 0.26% | 80 |
|
|
2020
Q1 | $479M | Buy |
7,218,568
+3,464,113
| +92% | +$244M | 0.28% | 72 |
|
|
2019
Q4 | $258M | Buy |
3,754,455
+50,366
| +1% | +$3.43M | 0.14% | 136 |
|
|
2019
Q3 | $272M | Buy |
3,704,089
+7,131
| +0.2% | +$517K | 0.16% | 120 |
|
|
2019
Q2 | $265M | Buy |
3,696,958
+70,060
| +2% | +$4.97M | 0.16% | 117 |
|
|
2019
Q1 | $249M | Buy |
3,626,898
+127,497
| +4% | +$8.24M | 0.16% | 118 |
|
|
2018
Q4 | $208M | Buy |
3,499,401
+125,554
| +4% | +$7.86M | 0.16% | 113 |
|
|
2018
Q3 | $226M | Buy |
3,373,847
+140,148
| +4% | +$9.33M | 0.15% | 121 |
|
|
2018
Q2 | $210M | Buy |
3,233,699
+70,318
| +2% | +$4.6M | 0.15% | 123 |
|
|
2018
Q1 | $227M | Sell |
3,163,381
-237,060
| -7% | -$17.1M | 0.18% | 102 |
|
|
2017
Q4 | $256M | Buy |
3,400,441
+13,791
| +0.4% | +$1.01M | 0.2% | 84 |
|
|
2017
Q3 | $247M | Sell |
3,386,650
-1,567
| -0% | -$113K | 0.22% | 77 |
|
|
2017
Q2 | $251M | Sell |
3,388,217
-85,977
| -2% | -$6.38M | 0.24% | 73 |
|
|
2017
Q1 | $254M | Buy |
3,474,194
+39,843
| +1% | +$2.79M | 0.25% | 63 |
|
|
2016
Q4 | $225M | Buy |
3,434,351
+875,092
| +34% | +$60M | 0.25% | 67 |
|
|
2016
Q3 | $190M | Buy |
2,559,259
+60,454
| +2% | +$4.47M | 0.22% | 78 |
|
|
2016
Q2 | $183M | Buy |
2,498,805
+48,467
| +2% | +$3.45M | 0.23% | 76 |
|
|
2016
Q1 | $173M | Sell |
2,450,338
-607,952
| -20% | -$40.4M | 0.23% | 78 |
|
|
2015
Q4 | $204M | Buy |
3,058,290
+233,585
| +8% | +$15.5M | 0.27% | 67 |
|
|
2015
Q3 | $179M | Buy |
2,824,705
+45,208
| +2% | +$2.95M | 0.26% | 70 |
|
|
2015
Q2 | $182M | Buy |
2,779,497
+6,229
| +0.2% | +$423K | 0.25% | 76 |
|
|
2015
Q1 | $192M | Buy |
2,773,268
+153,063
| +6% | +$10.6M | 0.27% | 70 |
|
|
2014
Q4 | $181M | Buy |
2,620,205
+191,416
| +8% | +$12.9M | 0.27% | 70 |
|
|
2014
Q3 | $158M | Buy |
2,428,789
+88,877
| +4% | +$5.86M | 0.26% | 73 |
|
|
2014
Q2 | $160M | Buy |
2,339,912
+97,493
| +4% | +$6.53M | 0.27% | 67 |
|
|
2014
Q1 | $145M | Buy |
2,242,419
+27,808
| +1% | +$1.75M | 0.26% | 72 |
|
|
2013
Q4 | $144M | Buy |
2,214,611
+101,316
| +5% | +$6.48M | 0.28% | 70 |
|
|
2013
Q3 | $127M | Buy |
2,113,295
+112,494
| +6% | +$6.67M | 0.26% | 84 |
|
|
2013
Q2 | $116M | Buy |
+2,000,801
| New | +$119M | 0.26% | 76 |
|
Other funds holding CL
VCM
DAM
VPM
Charles Schwab's CL Position: Q1 2026 in Review
Charles Schwab increased its Colgate-Palmolive (CL) stake by 3.5% in Q1 2026, buying an estimated $15.4M and bringing the position to 5,121,302 shares worth $436M. The position accounts for 0.07% of the portfolio, ranked #243.
Charles Schwab first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $628M in Q4 2021. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Charles Schwab held 5,121,302 shares of Colgate-Palmolive worth $436M as of Q1 2026.
- Charles Schwab bought 172,372 Colgate-Palmolive shares in Q1 2026, an estimated $15.4M.
- Colgate-Palmolive made up 0.07% of Charles Schwab's portfolio in Q1 2026, its #243 holding.
- Charles Schwab first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
- Charles Schwab's Colgate-Palmolive position peaked at $628M in Q4 2021.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.